Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV
Por um escritor misterioso
Descrição
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19: Molecular Therapy
Intradermal DNA vaccine delivery using vacuum-controlled, needle-free electroporation: Molecular Therapy - Nucleic Acids
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies - ScienceDirect
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
Advancements in DNA vaccines against COVID-19
Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS- CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice
Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study) - eClinicalMedicine
INOVIO COVID-19 Vaccine Trial Update - December 2020 - Penn Medicine
Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS- CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice
Positive Results from Preclinical Testing Support Clinical Development of COVID-19 DNA Vaccine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
